RDS | Rheumatologic Dermatology Society



3rd International Conference on Cutaneous Lupus (ICCLE) AgendaScotland - May 6 - 8, 2013Satellite meeting of the International Investigative Dermatology ConferenceSurgeons' Hall Edinburgh, Scotland, UKMay 6-8, 2013About the ConferenceInternational Investigative Dermatology 2013 (IID 2013) is the five-yearly scientific meeting of the European Society for Dermatological Research, Society for Investigative Dermatology and Japanese Society for Investigative Dermatology and includes several pre- and post-satellite meetings. Approximately 2,000 delegates attend the meeting which combine prestigious guest lectures, plenary and concurrent sessions, sponsored symposia, poster presentations, a rich educational program and more. The ICCLE conference, which is conducted in English, is a scientific meeting on Cutaneous Lupus Erythematosus and related autoimmune diseases. This satellite meeting of the International Investigative Dermatology conference will bring together researchers, clinicians, young scientists and residents to assess the state-of-the-art, discuss controversy and present new data. It will lay important groundwork for further developments in the field. May 6, 2013 (Monday)9:00-9:10 Opening remarks Pathogenesis of CLE and DMModerators: Jan Dutz and Fukumi FurukawaLupus9:10-9:40 Animal models of interface dermatitis, (Dutz)9:40-10:10 Trex1 in CHLE (Lee-Kirsch)10:10-10:40 Antimicrobial peptides in CLE (Gl?ser)10:40-11:00 Break and Poster viewingDermatomyositis11:00-11:30 Autoantibodies in DM (Fiorentino)11:30-12:00 Japanese studies with autoantibodies (Manubo Fujimoto)12:00-12:30 Animal models of myositis (Okiyama)Lunch 12:30-1:15 and Poster viewingDefinition and Diagnosis of lupus Moderators: Filippa Nyberg and J?rg Wenzel Lupus1:15-1:30 Introduction of approach (Werth)1:30-1:45 Delphi approach: history (Merola)1:45-2:15 Diagnostic vs classification criteria; and current definition and diagnostic criteria of CLE (Connolly)2:15-2:45 Histology of CLE (Wenzel)2:45-3:15 Definition of CLE/SLE vs CLE (Chong) 3:15-3:30 Break3:30-3:45 Consensus related to definitions and diagnosis of CLE (Nyberg) 4:00-6:00 (small groups)How do we want to define CLEList of all potential cutaneous lupus subsetsWhich criteria would be best to diagnose the different subtypes of CLE? (morphologic, serologic, histologic, other clinical features)Is there a need for a borderline form between CLE and SLE?Dinner on your ownTuesday, May 78:30-8:45 Report of small groups for definition and diagnosis 8:45-9:15 Synthesis: (Nyberg)EpidemiologyModerators: Thomas Ruzicka and Mark DavisLupus9:15-9:45 Population based incidence/prevalence of CLE in US (Mark Davis) 9:45-10:15 Subtypes of lupus in Asia (Furukawa)10:15-10:45 Break 10:45-11:30 Poster Viewing (presenters at their posters)11:30-12:00 Epidemiology of CLE: incidence, prevalence, medications, cancer (Nyberg)12:00-12:20 EUSCLE update, including Core Set Questionnaire (Kuhn)Lunch 12:20-1:00DermatomyositisModerators: Mark Goodfield and David Fiorentino1:00-1:30 Population based incidence of DM (Davis)1:30-2:00 Lung disease and DM (Ang)2:00-2:30 Cancer and DM (Hasegawa)2:30-3:00 QoL in CLE and DM (Verma)Break 3:00-3:15Classification (CLE, CLE/SLE, SLE, DM)Moderator: Lela Lee and Annegret KuhnLupus3:15-3:45 Current categorizations of CLE and lupus-nonspecific skin lesions; (Costner) 3:45-3:55 Dusseldorf Classification of CLE (Kuhn)3:55-4:25 Classification criteria for SLE (Zoma)Discussion: Potential Categorization of of lupus specific and lupus nonspecific skin lesions (Lela Lee) (4:25-4:40)4:40-6:00 (small groups)What is the purpose of the groupings of CLE subtypes?Do we need a new way to group subtypes of CLE, e.g. of LE-specific and LE-non-specific manifestationsWhat should these groupings look like?DinnerWednesday, May 88-8:15 In memorium of Thomas Provost (Sontheimer)8:15-8:45 small group leaders presentation8:45-9:30 Synthesis (Lela Lee)9:30-10:15 Discussion about next steps DermatomyositisModerators: Sontheimer10:15-10:45 Amyopathic DM and classification (Sontheimer)10:45-11:15 Classification criteria for DM (Lundberg)Break 11:15-11:30 TreatmentModerators: Werth and SzepietowskiLupus11:30-11:45 Treatment of CLE (Jessop)11:45-12:00 Impact of smoking (Meggitt)12:00-12:15 Vitamin D and lupus (Wittmann)12:15-12:30 Topical treatment in CLE (Ruzicka)12:30-12:45 Use of antimalarials (Frances)12:45-1:00 Thalidomide and Lenalidomide (Ordi Ros)1:00-1:45 Lunch1:45-2:00 Dapsone and retinoids (Aberer)2:00-2:15 Stem Cell Therapy and LE (Goodfield)2:15-2:30 New clinical treatments in CLE (Werth)2:30-2:45 Current practice variations in cutaneous lupus therapy and thoughts about international guidelines (Szepietowski)Dermatomyositis2:45-3:00 Treatment of dermatomyositis (Volc-Platzer) ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download